Brind.

AbCellera and Jazz Pharmaceuticals are both companies operating within the biomedical industry.

1 report, 1 independent Updated Jul 22

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Jazz Pharmaceuticals AbCellera

Keep exploring

The entities involved

Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
- Multiple financial firms adjusted their holdings in Jazz Pharmaceuticals stock and filed reports with the SEC on October 24, 2026.Sat 14:00
- Jazz Pharmaceuticals plans U.S. launch of Ziihera.Fri 16:12
AbCellera
company in Vancouver, Canada
- AbCellera plans to present at a conference taking place in London.Thu 22:09

Coverage

Newest first; wire copies grouped

Jul 22ZacksStrength Seen in ABCELLERA BIOLG (ABCL): Can Its 15.0% Jump Turn into More Strength? AbCellera Biologics Inc. (ABCL) shares rallied 15% in the last trading session to close at $5.15. This move can be